As announced in the recently published Q2 interim report, the Board of Directors of Chr. Hansen regrettably announces that CFO Søren Westh Lonning has decided to pursue his career outside of Chr. Hansen as CFO of a private equity backed, non-competitive company. Søren Westh Lonning has been with Chr. Hansen since 2007, and has been the CFO since 2015. He will leave his position at Chr. Hansen after the full-year report of the 2019/20 financial year. A search for a new CFO will begin immediately, and will consider both internal and external candidates.
Mauricio Graber, CEO of Chr. Hansen, said: “Søren has been a valued colleague in Chr. Hansen and a valued member of my leadership team. In his more than 12 years with Chr. Hansen, and the last 5 as CFO, he has left a very positive mark on the company and achieved outstanding results. I want to thank him for his time here, and his leadership and contributions will be missed. Most recently I have valued his contributions in leading the strategy review process together with me and in close collaboration with the corporate leadership team. I wish him the best of luck in the next step in his career.”
Søren Westh Lonning, CFO of Chr. Hansen, said: “I am truly grateful for the opportunities that I have been given in Chr. Hansen, and I will certainly miss many talented colleagues from the entire organization. I leave Chr. Hansen with a sense of accomplishment, and I believe the company is in great shape and with an exciting future ahead. I sincerely value the close collaboration with our CEO Mauricio Graber and the corporate leadership team. ”
Søren Westh Lonning will continue to serve on the Executive Board, together with CEO Mauricio Graber and CSO Thomas Schäfer, for the remainder of his tenure with Chr. Hansen, and his successor will replace him in the Executive Board. The Executive Board is appointed by the Board of Directors and is responsible for the day-to-day management within the guidelines and directions given by the Board of Directors.
Chr. Hansen ist ein weltweit tätiges, breit aufgestelltes Biotechnologie-Unternehmen, das Lösungen mit natürlichen Inhaltsstoffen für die Lebensmittel-, Ernährungs-, Pharma- und Agrarindustrie entwickelt. Bei Chr. Hansen sind wir hervorragend positioniert, um positive Veränderungen durch mikrobielle Lösungen voranzutreiben. Seit fast 150 Jahren setzen wir uns für eine nachhaltige Landwirtschaft, bessere Lebensmittel und ein gesünderes Leben für mehr Menschen auf der ganzen Welt ein. Unsere mikrobielle Plattform und Fermentationstechnologie, einschließlich unseres vielfältigen und beeindruckenden Bestands von rund 50.000 mikrobiellen Stämmen, besitzen bahnbrechendes Potenzial. Abgestimmt auf Kundenbedürfnisse und internationale Trends erschließen wir weiterhin die Kraft guter Bakterien, um auf weltweite Herausforderungen wie Lebensmittelverschwendung, globale Gesundheit und den übermäßigen Einsatz von Antibiotika und Pestiziden zu reagieren. Als das weltweit nachhaltigste Biotechnologie-Unternehmen berühren wir jeden Tag das Leben von mehr als 1 Milliarde Menschen. Unser Ziel „Grow a better world. Naturally“ wird angetrieben durch unsere Innovationsgeschichte, Neugierde und Pionierarbeit in der Wissenschaft und ist das Herzstück von allem, was wir tun.
